engaging podcast series covering various exciting subjects direct from Dr. Blevins’ desk
On today’s podcast and Cushing’s awareness day and month, we bring you a few excerpts from our soon-to-be-released new book on Cushing’s. The book’s author and Pituitary World News cofounder, Dr. Lewis Blevins, reads from a few selected chapters to give insight into the book’s content.
In this brief podcast, Dr. Blevins relates a fascinating Cushings case to talk about the importance of understanding disease patterns and how depth of knowledge gives physicians the critical skills to recognize unusual conditions.
Noncompliance with required follow-up visits and properly taking medications is a serious issue. Dr. Blevins tackles this problem with real clinical examples in this brief podcast.
In this podcast from our “musings series” comes an interesting discussion on lab result targets. This case comes from a hypothyroid patient who wanted to achieve a particular TSH lab result target. In the discussion, Dr. Blevins focuses on how the pituitary works, how lab tests work, and what makes aiming at and achieving a narrow target almost impossible.
In this podcast oriented to physicians, Dr. Lewis Blevins talks about a case of a patient with a pituitary lesion called a hemangiopericytoma invasive in the right cavernous sinus. Although the content is technical, patients and other interested parties may find the discussion interesting.
What happens when the insurance company’s first line of response is to deny, deny, deny? How does this increase in oversight from third-party payors impact the process of rare pituitary disease medicine authorizations indicated for treatment?
Acromegaly: what to do with medical treatment during pregnancy and the options available today.
An informal discussion of Cushing’s disease issues from cases, articles, and experiences with patients.
Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.
Interesting inquiries prompted by the questions patients leave in their health portals.
Two patients with residual pituitary tumors and their unpredictable differences.
Telemedicine, how practices have adapted, views on pros and cons, and how things may change in the future.